Synapse Speaker List

Total Page:16

File Type:pdf, Size:1020Kb

Synapse Speaker List Shernaz Bamji, PhD University of British Columbia Professor, Department of Cellular and Physiological Sciences Head, LSI Neuroscience Research Group, Life Sciences Institute Djavad Mowafaghian Center for Brain Health School of Biomedical Engineering Shernaz Bamji received her Ph.D. at McGill University and did her postdoctoral training at the University of California, San Francisco. Dr. Bamji is currently a full professor in the Department of Cellular and Physiological Sciences at the University of British Columbia and is Vice- President elect of the Canadian Association for Neurosciences. Dr. Bamji has a long-standing interest in understanding the molecular and cellular mechanisms underlying neural connectivity and synaptic plasticity. Her work has provided valuable information about fundamental mechanisms underlying learning and memory, as well as how these processes are perturbed in diseased states. https://www.bamjilab.com/ Nils Brose, PhD Max Planck Institute for Experimental Medicine Professor, Department of Molecular Neurobiology Nils Brose studied Biochemistry, Biology, and physiology at the Universities of TueBingen (Germany) and Oxford (UK). He conducted his PhD work with Reinhard Jahn at the Max Planck Institute of Psychiatry in Martinsried (Germany) and then did postdoc studies with Steve Heinemann at the Salk Institute in La Jolla (CA, USA) and with Tom Suedhof at the University of Texas Southwestern Medical Center in Dallas (TX, USA). SuBsequently, Nils Brose was a Research Group Leader at the Max Planck Institute of Experimental Medicine in Goettingen (Germany), where he has Been the Director of the Department of Molecular NeuroBiology since 2001. Nils Brose's research focusses on the molecular mechanisms that control the formation and function of synapses between nerve cells. One of his key research interests concern the mechanisms of synaptic vesicle fusion. He pioneered the characterization of synaptic vesicle priming as a key step in transmitter release and as a major regulatory process in synapse efficacy and plasticity. In his seminar, Nils Brose will present recent studies on the control of synaptic vesicle priming and on the role of this process in controlling synapse efficacy under physiological and pathophysiological conditions. http://www.em.mpg.de/ Pablo Castillo, MD, PhD Albert Einstein College of Medicine Professor, Dominick P. Purpura Department of Neuroscience Professor, Department of Psychiatry and Behavioral Sciences Harold and Muriel Block Chair in Neuroscience Dr. PaBlo Castillo is the Harold and Muriel Block Professor of Neuroscience and Psychiatry at the AlBert Einstein College of Medicine in New York City. He received his MD and PhD degrees from the Universidad de la República in Uruguay, and postdoctoral training at the University of California, San Francisco and Stanford University. Dr. Castillo is a world expert in synaptic plasticity, a biological process critically involved in experience-dependent modifications of Brain function. He has made significant contributions to our understanding of various forms of activity-dependent plasticity at both excitatory and inhibitory synapses under normal and pathological conditions. In his studies, he comBines molecular, genetic, pharmacological and electrophysiological techniques in the mammalian Brain. His work has been largely published in top tier journals, and he is the author of several widely cited review articles and book chapters. http://www.einstein.yu.edu/faculty/8363/paBlo-castillo/ Aaron DiAntonio, MD, PhD Washington University School of Medicine Alan A. and Edith L. Wolff Professor of Developmental Biology, Department of Developmental Biology Co-Director of the Needleman Center for Neurometabolism and Axonal Therapeutics Dr. Aaron DiAntonio is the Alan A. and Edith L. Wolff Professor in the Department of Developmental Biology and co-Director of the Needleman Center for NeurometaBolism and Axonal Therapeutics at the Washington University School of Medicine. His laboratory combines genetics, cell biology, biochemistry, and physiology in both Drosophila and mouse to investigate molecular mechanisms that control the formation, maintenance, and repair of neural circuits in development and disease. His laboratory is now translating these fundamental mechanistic insights into novel therapies for the treatment of neurological disease. Dr. DiAntonio is a scientific founder and co-chair of the Scientific Advisory Board for Disarm Therapeutics. https://sites.wustl.edu/diantonio/ Felice Dunn, PhD University of California San Francisco Assistant Professor of Ophthalmology, Department of Ophthalmology Member, Neuroscience Graduate Program Felice Dunn Began her studies in neuroscience as an undergraduate at Brown University where she worked with David Berson in the discovery of intrinsically photosensitive ganglion cells. She then continued her studies in vision at the University of Washington with Fred Rieke as a graduate student and with Rachel Wong as a postdoctoral fellow. With Fred Rieke, she examined retinal gain controls that enable vision across a broad range of mean light levels. With Rachel Wong, she uncovered developmental patterns of synapse formation. In Between, she studied the fidelity of olfactory processing at the NIH with Mark Stopfer. Currently at UCSF, her laB examines the structural and functional effects of synapse loss, and her laB recently uncovered resilience within the adult retina. http://vision.ucsf.edu/dunnlab/research.html Cagla Eroglu, PhD Duke University School of Medicine Associate Professor of Cell Biology, Department of Cell Biology Associate Professor of Neurobiology, Department of Neurobiology Cagla Eroglu, Ph.D. is Associate Professor of Cell Biology and NeuroBiology, Director of Graduate Studies in Cell and Molecular Biology and Co-Director, Regeneration Next Initiative, Duke University. Dr. Eroglu’s laBoratory investigates the cellular and molecular underpinnings of how synaptic circuits are established and remodeled in the mammalian brain by the bidirectional signaling between neurons and glia and how disruption of these mechanisms contributes to the pathogenesis of neurological disorders. http://www.cellbio.duke.edu/cagla-eroglu Kristen Harris, PhD The University of Texas at Austin Professor, Department of Neuroscience Fellow, Center for Learning and Memory Institute for Neuroscience Kristen M. Harris received her PhD (1982) at Northeastern Ohio University College of Medicine and Kent State, and then completed her postdoctoral training (1982-84) at the Massachusetts General Hospital and Harvard Medical School. She was on the Neuroscience faculty of Harvard Medical School (1984-99) and Boston University (1999-02). She was a Professor, Georgia Research Alliance Eminent Scholar, and Director of the Synapses and Cognitive Neuroscience Center at the Medical College of Georgia (2002-2006). Currently, she is a Professor of Neuroscience and Fellow in the Center for Learning and Memory and Institute for Neuroscience at the University of Texas at Austin (since 2006). She has received prestigious awards, including the Sloan Research Fellowship, Javits Merit Award, and a Brain Research Foundation Fellowship, and is widely sought as a national and international speaker. She has had continuous independent funding for her research since she was a graduate student, and has participated on numerous study sections for the National Institutes of Health and elsewhere. She is known for innovative teaching in her laboratory and writing course for undergraduate and graduate students. Currently, she serves on the Scientific Advisory Boards for the Howard Hughes Medical Institute (HHMI) at Janelia Farms, The Max Planck Institute for Brain Research in Frankfurt Germany, and The Allen Institute for Brain Research. Scientific data and tools provided on her website (synapseweb.clm.utexas.edu) are widely used resources. http://synapseweb.clm.utexas.edu/ Richard L. Huganir, PhD Johns Hopkins School of Medicine Bloomberg Distinguished Professor Professor and Director, Solomon H. Snyder Department of Neuroscience Co-Director of the Brain Science Institute Richard Huganir is a BloomBerg Distinguished Professor and Professor and Director of the Solomon H. Snyder Department of Neuroscience at the Johns Hopkins School of Medicine and is the Co-Director of the Johns Hopkins Medicine Brain Science Institute. Dr. Huganir received his Ph.D. degree from Cornell University in 1982 and was a postdoctoral fellow with the NoBel Laureate, Paul Greengard, at Yale University School of Medicine from 1982-1984. Dr. Huganir then moved to Rockefeller University where he was an Assistant Professor from 1984-1988. Dr. Huganir moved to the Johns Hopkins University School of Medicine in 1988 as an Associate Investigator in the Howard Hughes Medical Institute and an Associate Professor in the Department of Neuroscience. Dr. Huganir was a Howard Hughes Medical Institute Investigator for 26 years from 1988-2014. Dr. Huganir Became the Director of the Solomon H. Snyder Department of Neuroscience in 2006. Dr. Huganir is the past the President of the Society for Neuroscience and has served as Treasurer of the Society for Neuroscience. He has received the Young Investigator Award and the Julius Axelrod Award from the Society for Neuroscience, the Santiago Grisolia Award, the Goldman-Rakic Award, the Edward M. Scolnick Prize and is a fellow of the American Association for the Advancement of Science, a member of the American Academy of Arts and Sciences, the National
Recommended publications
  • Briefbogen Mit Logo Schwarz/Weiß BI Stiftung
    Boehringer Ingelheim Stiftung Fusion for brain signals – 100,000 euro Heinrich Wieland Prize for Reinhard Jahn Mainz, Germany, August 7, 2014: Professor Reinhard Jahn has been selected as the recipient of the international Heinrich Wieland Prize for his paradigmatic studies on membrane fusion, synaptic vesicles, and neurotransmitter release – processes that occur when cells grow, 7. August 2014 transport substances, or signal. With the 100,000 euro prize the Boehringer Ingelheim Foundation is honouring the pioneering achievements of the Director at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany. To mark the 50th anniversary of the prize, the foundation will hold a scientific symposium and a festive award ceremony on October 21, 2014, in the Munich Residenz in Munich, Germany. Around 100 billion nerve cells are packed into the human brain, where they Dr. Claudia Walther constantly exchange signals. Despite their density, there remains a small gap Geschäftsführung between the individual cells. The signals are carried across this gap by molecules Schusterstraße 46-48 called neurotransmitters, which wait for their cue in the synaptic vesicles, the nerve 55116 Mainz cell’s tiny storage bubbles. To move into the gap, the neurotransmitters need to Telefon 06131 27 50 8 16 cross the cell membrane without breaching its integrity, as this could result in the Telefax 06131 27 50 8 11 death of the cell. The solution is elegant: the membranes of both the vesicle and the E-Mail: [email protected] cell fuse seamlessly, releasing the neurotransmitters into the gap. This process of membrane fusion is not confined to the brain, but occurs in all body cells when they grow, transport substances, or release hormones.
    [Show full text]
  • CV Than, NA Rosenberg
    Noah A. Rosenberg Department of Biology Stanford University Stanford, CA 94305-5020 USA (650) 721-2599 (phone) (650) 724-5114 (fax) [email protected] http://rosenberglab.stanford.edu/ August 9, 2017 Academic appointments 2014- Stanford Professor of Population Genetics and Society, Stanford University School of Humanities and Sciences 2014- Professor, Stanford University Department of Biology 2011-2014 Associate Professor, Stanford University Department of Biology 2009-2011 Associate Professor, University of Michigan Depts. of Human Genetics, Ecology & Evolutionary Biology, and Biostatistics Research Associate Professor, University of Michigan Life Sciences Institute and Center for Computational Medicine & Bioinformatics 2005-2009 Assistant Professor, University of Michigan Depts. of Human Genetics, Ecology & Evolutionary Biology (2006-2009), and Biostatistics Research Assistant Professor, University of Michigan Life Sciences Institute and Center for Computational Medicine & Bioinformatics Education 2001-2005 Postdoc, University of Southern California, Molecular and Computational Biology 1998-2001 PhD, Stanford University, Biological Sciences 1997-1999 MS, Stanford University, Mathematics 1993-1997 BA, Rice University, Mathematics and Russian Studies, summa cum laude Awards Fellowships 2007 Faculty Research Grant, University of Michigan Rackham Graduate School 2006 Faculty Fellowship Enhancement Award, University of Michigan Rackham Graduate School 2006-2010 Alfred P. Sloan Research Fellowship in Computational and Evolutionary Molecular
    [Show full text]
  • September 29 & 30, 2020
    SALTIEL LIFE SCIENCES SYMPOSIUM BROADENING THE BIOSCIENCES: EXPLORING DIVERSE APPROACHES TO BIOLOGICAL AND BIOMEDICAL RESEARCH SEPTEMBER 29 & 30, 2020 NINETEENTH ANNUAL LSI SYMPOSIUM ZOOM WEBINAR #LSIsymposium2020 SCHEDULE TUESDAY, SEPTEMBER 29 2:00 P.M. TALK SESSION 2: SOCIAL BIOMIMICRY Welcome Roger D. Cone, Ph.D. 3:10 P.M. Vice Provost and Director, Biosciences Initiative; Towards living robots: Using biology to make better Mary Sue Coleman Director, Life Sciences Institute; machines Professor of Molecular and Integrative Physiology, Medical School; Professor of Molecular, Cellular, and Barry A. Trimmer, Ph.D. Developmental Biology, College of Literature, Science, Henry Bromfield Pearson Professor of Natural Sciences; and the Arts, University of Michigan Director, Neuromechanics and Biomimetic Devices Laboratory, School of Arts and Sciences, Tufts University Marschall S. Runge, M.D., Ph.D. Dean, Medical School, University of Michigan; Executive 4:05 P.M. Vice President, Medical Affairs, CEO, Michigan Medicine How the physics of slithering can teach multilegged robots to walk TALK SESSION 1: HUMAN ADAPTATION Shai Revzen, Ph.D. AND EVOLUTION Associate Professor of Electrical Engineering and Computer Science, College of Engineering, University of Michigan 2:10 P.M. Introduction of the Mary Sue and Kenneth Coleman Life 4:25 P.M. Sciences Lecturer What wasps can teach us about the evolution of Alan R. Saltiel, Ph.D. animal minds Professor and Director, Institute for Diabetes and Elizabeth Tibbetts, Ph.D. Metabolic Health, University of California San Diego Professor of Ecology and Evolutionary Biology, College School of Medicine; Director, Life Sciences Institute of Literature, Science, and the Arts, University of Michigan (2002–2015) 5:20 P.M.
    [Show full text]
  • Angela N. Koehler
    Angela N. Koehler Broad Institute of MIT and Harvard Office: 617-714-7364 Chemical Biology Program Fax: 617-714-8943 7 Cambridge Center Email: [email protected] Cambridge, MA 02142 Website: www.broadinstitute.org/node/2445 Education Ph.D. Chemistry, Harvard University, 2003 B.A. Biochemistry and Molecular Biology, Reed College, 1997 Research Experience Investigator, Chemical Biology Program, Broad Institute 2009-present Project & Center Manager, Broad NCI Cancer Target Discovery and Development (CTD2) Center 2010-2012 Institute Fellow, Chemical Biology Program, Broad Institute 2003-2009 Director, Ligand Discovery, NCI Initiative for Chemical Genetics (ICG) at Harvard 2003-2009 Graduate Student, Department of Chemistry and Chemical Biology, Harvard University 1998-2003 Laboratory of Professor Stuart L. Schreiber Thesis: Small molecule microarrays: A high-throughput tool for discovering protein-small molecule interactions Researcher, Department of Chemistry, California Institute of Technology 1997-1998 Laboratory of Professor Barbara Imperiali Project: Biochemical reconstitution of the oligosaccharyltransferase (OST) complex Undergraduate Researcher, Department of Chemistry, Reed College 1995-1997 Laboratory of Professor Arthur Glasfeld Co-mentored by Professor Richard G. Brennan at Oregon Health Sciences University Thesis: Biochemical and structural characterization of the tRNA-modifying enzyme QueA from Escherichia coli Teaching Experience Research Advisor to postdoctoral fellows, undergraduates, high school students, and staff scientists 2003-present Broad Institute of MIT and Harvard Instructor, Biochemical Sciences Research (BS91r) 2004-2006, 2010-2011 Harvard University Associated Instructor, Experimental Research in the Life Sciences (LS100r) 2009 Harvard University Associated Instructor, Experimental Molecular and Cellular Biology (MCB100) 2004-2006 Harvard University Teaching Fellow, Chemical Biology (Chem 170) 1999, 2000 Harvard University, Professor David R.
    [Show full text]
  • Dysregulated Hematopoiesis Caused by Mammary Cancer Is Associated with Epigenetic Changes and Hox Gene Expression in Hematopoietic Cells Alexander Sio1*, Manreet K
    Author Manuscript Published OnlineFirst on August 1, 2013; DOI: 10.1158/0008-5472.CAN-13-0842 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and Hox gene expression in hematopoietic cells Alexander Sio1*, Manreet K. Chehal1*, Kevin Tsai1, Xueling Fan1, Morgan E. Roberts1, Brad H. Nelson2, Jolanta Grembecka3, Tomasz Cierpicki3, Danielle L. Krebs1 and Kenneth W. Harder1 1Department of Microbiology and Immunology, I3 Research Group, Life Sciences Institute, University of British Columbia, Vancouver, B.C., Canada. 2Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, B.C., Canada. 3Department of Pathology, University of Michigan, Ann Arbor, MI., USA. *Authors contributed equally to this work. Running Title: MAMMARY CANCER INDUCES DEFECTS IN HEMATOPOIESIS Keywords: hematopoiesis, mammary tumors, HOXA9, G-CSF, epigenetics Supported by grants from the Canadian Breast Cancer Foundation (KWH, DLK) and Canadian Institutes of Health Research (CIHR, KWH, CIHRMOP-86694). KWH holds a Tier-II Canada Research Chair. Studentships to MKC (Michael Smith Foundation and CIHR), MER (CIHR Training Program in Transplantation), and XF (University of British Columbia/4YF) helped support these studies. Correspondence: Kenneth W. Harder, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver, B.C., V6T-1Z3; e-mail: [email protected] Word Count: Total number of figures and tables: 7 Conflict-of-interest disclosure: The authors declare no competing financial interests. 1 Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 2013 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 1, 2013; DOI: 10.1158/0008-5472.CAN-13-0842 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • International Max Planck Research School
    Georg-August-Universität Göttingen International Max Planck Research School Neurosciences Max Planck Institutes for • Biophysical Chemistry MSc/PhD/MD-PhD Program • Experimental Medicine • Dynamics and Self- Organization DPZ German Primate Center Gottingen European Neuroscience Institute Göttingen www.gpneuro.uni-goettingen.de YEARBOOK 2013 / 2014 MSc/PhD/MD-PhD Neuroscience Program at the University of Göttingen International Max Planck Research School Yearbook 2013/2014 Yearbook Index / Imprint Letter from the University ...........................................................................................................................................1 Letter from the Max Planck Society ............................................................................................................................2 Overview .....................................................................................................................................................................3 Funding of the program ..............................................................................................................................................4 Donors ........................................................................................................................................................................5 Intensive Course Program (First Year) ........................................................................................................................6 Lectures and Tutorials .................................................................................................................................................6
    [Show full text]
  • Angela N. Koehler
    Angela N. Koehler Koch Institute for Integrative Cancer Research at MIT Office: 617-324-7631 Department of Biological Engineering, MIT Email: [email protected] 76-361C Website: http://koehler-lab.mit.edu/ 77 Massachusetts Avenue Cambridge, MA 02139 Education Ph.D. Chemistry, Harvard University 2003 B.A. Biochemistry and Molecular Biology, Reed College 1997 Professional Appointments Associate Professor, Department of Biological Engineering, MIT 2019-present Institute Member, Broad Institute of MIT and Harvard 2019-present Founding Member, MIT Center for Precision Cancer Medicine 2018-present Goldblith Career Development Professor in Applied Biology 2018-2021 Intramural Faculty, Koch Institute for Integrative Cancer Research at MIT 2014-present Assistant Professor, Department of Biological Engineering, MIT 2014-2018 Karl Van Tassel (1925) Career Development Professor 2014-2017 Director, Transcriptional Chemical Biology, Chemical Biology Program, Broad Institute 2010-2013 Project & Center Manager, Broad NCI Cancer Target Discovery and Development (CTD2) Center Institute Fellow, Chemical Biology Program, Broad Institute 2003-2009 Director, Ligand Discovery, NCI Initiative for Chemical Genetics (ICG) at Harvard Research Training Graduate Student, Department of Chemistry and Chemical Biology, Harvard University 1998-2003 Laboratory of Professor Stuart L. Schreiber Committee: Professors Eric. N. Jacobsen, David R. Liu Thesis: Small molecule microarrays: A high-throughput tool for discovering protein-small molecule interactions Researcher, Department
    [Show full text]
  • Molecular Biology
    Introduction 6 An expedition into the world of molecules 6 Research without constraints 8 Content Tradition and vision 10 Teaching and learning 12 When a new idea ignites 14 Open doors 16 Looking deeper 18 NanoBiophotonics 20 Stefan W. Hell Structure and Dynamics of Mitochondria 22 Stefan Jakobs Laboratory of Cellular Dynamics 24 Thomas M. Jovin Electron-Spin Resonance Spectroscopy 26 Marina Bennati Nanoscale Spin Imaging 28 Sophisticated molecules 40 Gopalakrishnan Balasubramanian Biological Micro- and Nanotechnology 30 Theoretical and Computational Biophysics 42 Thomas Burg Helmut Grubmüller Spectroscopy and Photochemical Kinetics 32 Computational Biomolecular Dynamics 44 Jürgen Troe Bert L. de Groot Structural Dynamics of (Bio)Chemical Processes 34 NMR-based Structural Biology 46 Simone Techert Christian Griesinger Dynamics at Surfaces 36 Structure Determination of Proteins Using NMR 48 Alec M. Wodtke Markus Zweckstetter Precision Infrared Spectroscopy on Small Molecules 38 Bioanalytical Mass Spectrometry 50 Samuel Meek Henning Urlaub 4 Cellular machines 52 From egg to organism 80 Molecular Biology 54 Meiosis 82 Patrick Cramer Melina Schuh Quantitative and Computational Biology 56 Molecular Developmental Biology 84 Johannes Söding Herbert Jäckle Cellular Biochemistry 58 Gene Expression and Signaling 86 Reinhard Lührmann Halyna R. Shcherbata Macromolecular Crystallography 60 Molecular Organogenesis 88 Vladimir Pena Reinhard Schuh Physical Biochemistry 62 Molecular Cell Differentiation 90 Marina V. Rodnina Ahmed Mansouri Ribosome Dynamics
    [Show full text]
  • Life Sciences Institute .Pdf
    CENTERS & TECHNOLOGIES Along with its faculty labs, the LSI is also home to specialized core laboratories and cutting-edge resources to advance basic biology and drug discovery projects. Most are open to U-M investigators and external users. Center for Chemical Genomics • High-throughput screening for basic biology & drug discovery • 160,000 chemical compounds & 40,000 natural product extracts • High-throughput assay development & optimization • Target validation & pathway analysis Center for Structural Biology • High-throughput protein laboratory for protein engineering • Protein purification facility (small & large protein production) • Macromolecular crystallization & crystallography labs DISCOVERY • Access to synchrotron at Argonne National Laboratory UNBOUNDED Cryo-Electron Microscopy • Advanced instrumentation platform for various levels of About the Life Sciences Institute molecular characterization Our mission is to advance the understanding of • High-resolution capabilities through an FEI Arctica & the fundamental processes of life, and to pioneer a Titan Krios equipped with Gatan K2 Summit direct new ideas to improve human health. electron detectors Our faculty members have broad and diverse • Funding from the U-M Biosciences Initiative to add expertise — ranging from cell biology to cryo-electron tomography and other advances medicine, from chemistry to structural biology. And the LSI provides them with a research Mass Spectrometry home purposefully designed to foster creative • Open and assisted services for the analysis of
    [Show full text]
  • An Opportunity to Build “One Missouri”
    LIFE SCIENCES & MISSOURI’S ECONOMIC FUTURE: AN OPPORTUNITY TO BUILD “ONE MISSOURI” PREPARED FOR: The State of Missouri The University of Missouri System The Danforth Foundation The Ewing Marion Kauffman Foundation PREPARED BY: Technology Partnership Practice Battelle Memorial Institute Cleveland, Ohio January 2003 © 2003 Battelle Memorial Institute © 2003 Battelle Memorial Institute (Battelle) does not endorse or recommend particular companies, products, services, or technologies, nor does it endorse or recommend financial investments and/or the purchase or sale of securities. Battelle makes no warranty or guarantee, express or implied, including without limitation, warranties of fitness for a particular purpose or merchantability, for any report, service, data, or other information provided herein. Copyright 2003 Battelle Memorial Institute. Use, duplication, or distribution of this document or any part thereof is prohibited without the written permission of Battelle Memorial Institute. Unauthorized use may violate the copyright laws and result in civil and/or criminal penalties. Final Report Life Sciences & Missouri’s Economic Future: An Opportunity to Build “One Missouri” Prepared for: The State of Missouri The University of Missouri System The Danforth Foundation The Ewing Marion Kauffman Foundation Prepared by: Technology Partnership Practice Battelle Memorial Institute Cleveland, Ohio January 2003 “One Missouri” PREFACE “One Missouri” represents an opportunity for the State of Missouri, in partnership with industry, philanthropic sources, and others, to engage in a multiyear effort to position the state as a major Midwest Center in the life sciences, with world-class research stature translated into wealth creation and well-paying jobs for the state’s current and future generations. But, Missouri is lagging other states, in the Midwest and elsewhere, and the current state budgetary crisis is moving the state backwards.
    [Show full text]
  • Executive Summary
    THE LIFE SCIENCES INSTITUTE DIABETES : BIOMARKERS TO CURES Diabetes expertise at the UBC Life Sciences Institute 7% of Canadians live with diabetes. Their As of 2014, 387 million people worldwide suffer with diabetes at a stunning cost of over $450 billion annual direct medical costs are expected to for medical attention. The complexity of this disease – reach $16.9 billion by 2020. due to its multi-genetic nature and the innate genetic differences of individuals within this population – has Only ~50% of conventional therapies are perplexed scientists for decades. With advances in effective in the person for whom they are our understanding of the mechanisms underlying this prescribed and many cause adverse side disease, we are poised to better understand the complex effects. Personalized diagnosis is key to nature of diabetes and how to more effectively diagnose, treatment. treat, and one day cure this devastating disease. Researchers in the Life Sciences Institute (LSI), the The Life Sciences Institute Diabetes Research largest institute of its kind in Canada, are positioned to Group is a leading team of experts dedicated take a lead in unraveling medicine’s greatest challenges and providing the data needed by the healthcare to tackling diabetes for better diagnosis and system through an evidence-based approach to achieve treatment. more precise management of health and treatment of disease. The LSI Diabetes Research Group, with its upon drugs. It has been estimated that diabetes reduces unique complement of diabetes research programs, has lifespan on average by 15 years. In fact, deaths due to considerable expertise in the areas of molecular biology, diabetes-related causes approach those of all cancers genetics, biochemistry, cell biology and physiology.
    [Show full text]
  • MINKUI LUO, PH.D. 1 | Page Chemical Biology Program Phone
    MINKUI LUO, PH.D. Chemical Biology Program Phone: (646)-888-3066 Memorial Sloan Kettering Cancer Center Fax: (646)-888-3166 1275 York Avenue, Box 248 Email: [email protected] New York, NY 10065 Web: www.mskcc.org/luo PERSONAL Born: Sep. 20th, 1976; Urumqi, Xinjiang, China Citizenship: China (US permanent resident) ACADEMIC APPOINTMENTS 2019-present Member of Chemical Biology, Memorial Sloan Kettering Cancer Center 2019-present Professor of Pharmacology, Weill Medical College of Cornell University 2019-present Professor of Tri-Institute Program of Chemical Biology 2019-present Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences 2014-2019 Associate Member of Chemical Biology, Memorial Sloan Kettering Cancer Center 2014-2019 Associate Professor of Pharmacology, Weill Medical College of Cornell University 2014-2019 Associate Professor of Tri-Institute Program of Chemical Biology 2014-2019 Associate Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences 2008-2014 Assistant Member of Chemical Biology, Memorial Sloan Kettering Cancer Center 2008-2014 Assistant Professor of Pharmacology, Weill Medical College of Cornell University 2008-2014 Assistant Professor of Tri-Institute Program of Chemical Biology 2008-2014 Assistant Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences 2008-2014 Assistant Member of Mol. Pharm. & Chem., Memorial Sloan Kettering Cancer EDUCATION & TRAINING 2005-2008 Postdocoral Fellow in Biochemistry & Chemical Biology, Albert Einstein College of Medicine, with
    [Show full text]